Ken Huber, MD

Original Contribution

Utility of Sirolimus-Eluting Cypher‚Ñ¢ Stents to Reduce 12-Month
Target Vessel Revascularization in Saphenous Vein Graft Stenoses

08/01/2008

Dean J. Kereiakes , MD, FACC, FSCAI;

Stephen G. Ellis , MD;

David E. Kandzari , MD;

Ken Huber , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Frederic S. Resnic , MD, MSc;

Steven J. Yakubov , MD;

Keith Callahan , MPH;

Marilyn Borgman , RN;

Sidney A. Cohen , MD, PhD;

Approximately 1 million patients are now treated annually in the United States with drug-eluting stents (DES). Usage of these stents is substantiated in many patient and lesion subsets by their documented relative safety and reduction in...

Approximately 1 million patients...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Ken Huber, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products